Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 132,542 | 231,900 | 57,587 | 121,561 | 156,591 |
| Marketable Securities | 286,210 | 234,178 | 228,813 | 197,176 | 191,668 |
| Receivables | 20,401 | 15,414 | 9,814 | 4,418 | 1,187 |
| Inventories | 26,266 | 19,326 | 19,293 | 17,376 | 15,936 |
| Other current assets | 0 | 796 | 0 | 0 | 0 |
| TOTAL | $477,618 | $513,324 | $329,219 | $349,689 | $372,246 |
| Non-Current Assets | |||||
| PPE Net | 4,332 | 4,418 | 4,551 | 4,813 | 4,758 |
| Investments And Advances | 0 | 0 | 0 | 5,004 | 12,603 |
| Intangibles | 7,882 | 8,404 | 8,926 | 9,291 | 9,854 |
| Other Non-Current Assets | 17,070 | 17,221 | 17,370 | 17,471 | 17,617 |
| TOTAL | $29,284 | $30,043 | $30,847 | $36,579 | $44,832 |
| Total Assets | $506,902 | $543,367 | $360,066 | $386,268 | $417,078 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 32,327 | 34,947 | 29,970 | 25,831 | 17,694 |
| Other current liabilities | 502 | 4,450 | 6,456 | 2,372 | 2,382 |
| TOTAL | $33,838 | $40,646 | $37,537 | $29,315 | $21,151 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 190 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 7,562 | 23,630 | 24,357 | 24,696 | 25,699 |
| TOTAL | $24,941 | $23,630 | $24,357 | $24,696 | $25,699 |
| Total Liabilities | $58,779 | $64,276 | $61,894 | $54,011 | $46,850 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 141,742 | 141,654 | 129,670 | 128,396 | 128,156 |
| Common Shares | 1,178,807 | 1,177,051 | 967,159 | 954,572 | 952,673 |
| Retained earnings | -793,752 | -756,122 | -722,800 | -672,545 | -625,535 |
| Other shareholders' equity | -1,618 | -852 | -794 | -792 | -799 |
| TOTAL | $448,123 | $479,091 | $298,172 | $332,257 | $370,228 |
| Total Liabilities And Equity | $506,902 | $543,367 | $360,066 | $386,268 | $417,078 |